Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Neogen Corp

NASDAQ: NEOG · Life Sciences · 5 alerts · CIK 711377

Share price
$10.88Close, Nov 16
Market cap
$2.38B
Shares outstanding
218.31MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Neogen Corp filings on SEC EDGAR ↗

4:11 PM ET Form 4
Insider Selling

Neogen CSO Jeremy Yarwood Sells $115K of Stock

Jeremy Yarwood, CSO, sold 9,051 shares of Neogen Corp at $12.67 a share, worth $115K in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).

Value
$115K
Shares
9,051
Price
$12.67
Role
CSO
Holding change
-100.0%
Trade date
Nov 4, 2026
4:01 PM ET 8-K
M&A Deal

Neogen M&A Deal with Zoetis Inc.

Neogen Corporation provided a status update on the pending sale of its global Genomics business to Zoetis Inc. To facilitate regulatory clearance from the ACCC and NZCC, Zoetis has offered to divest certain assets in Australia, with the transaction now expected to close in early 2027.

Counterparty
Zoetis Inc.
9:17 AM ET 8-K/A
Stock Plan Amendment

Neogen Stock Plan Amendment

Neogen Corporation's shareholders approved the Amended and Restated Omnibus Incentive Plan at the annual meeting held on October 1, 2026. The plan authorizes the issuance of up to 31,350,000 shares for various equity-based awards, including stock options and restricted stock units, for employees and non-employee directors. This filing amends a previous 8-K to specifically include the disclosure of this shareholder approval.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.